Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER). Issue 6 (June 2021) - Hafeez, S.; Lewis, R.; Hall, E.; Huddart, R.; ,; Birtle, A.; Choudhury, A.; Cresswell, J.; Foroudi, F.; Gribble, H.; Griffin, C.; Hafeez, S.; et al.